Eupraxia Pharmaceuticals Inc. (EPRX)
$6.68-8.74%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $224M
- Beta
- 1.50
- P/E (TTM)
- -6.62
- Short % float
- 26.32%
- Days to cover
- 11.1
- SI change
- -10.3%
- 1W
- -13.70%
- 1M
- -17.22%
- vs SPY 1W
- -13.56%
- vs SPY 1M
- -19.73%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on EPRX?
- LOPJLB’s latest quantitative signal on Eupraxia Pharmaceuticals Inc. (EPRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EPRX in?
- Eupraxia Pharmaceuticals Inc. (EPRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Eupraxia Pharmaceuticals Inc. (EPRX) do?
- Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee o…